Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ImpriMed

News headline image
ImpriMed Announces Findings on the Value of Personalized Cancer Care for Dogs
From ImpriMed
Via Business Wire
News headline image
ImpriMed Accelerates Growth With Strategic Leadership Hire and Major Operational Milestones
From ImpriMed
Via Business Wire
News headline image
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans
From ImpriMed
Via Business Wire
News headline image
ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences
From ImpriMed
Via Business Wire
News headline image
ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology
From ImpriMed
Via Business Wire
News headline image
ImpriMed to Showcase Groundbreaking AI Research and Applications at Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
From ImpriMed
Via Business Wire
News headline image
ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress
From ImpriMed
Via Business Wire
News headline image
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
From ImpriMed
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.